Meftinib 250mg Tablet is generally used for cancer management. It operates by attacking the epidermal growth factor receptor (EGFR) existing in both healthy and malignant cells, disrupting crucial signaling pathways for the proliferation of cancer cells.

Gefitinib is grouped under cancer drugs and is deployed to address certain types of cancers by curbing cancer cell proliferation. It homes in on the epidermal growth factor receptor (EGFR), that exists in both normal and cancerous cells. By obstructing particular proteins associated with this receptor, Gefitinib impedes the signal channels crucial for cancer cell proliferation and survival. Essentially, it puts a halt to the rampant proliferation of cancerous cells.

Adhere to the prescribed quantity and duration as instructed by your general physician. This medication can be consumed with or without meals but it is beneficial to maintain a regular time each day for best results.

Typical side effects might include diarrhea, arid skin, decreased appetite, queasiness, skin rash, stomatitis (inflammation in mouth), sickness, fatigue, and weight reduction.

It has been linked with an elevated danger of interstitial lung disease, a grave condition. Patients ought to be monitored for symptoms such as persistent cough, labored breathing, and high temperature. Immediate medical care is required if these symptoms manifest, and medication may need to be paused or halted.

Should a dosage be missed, consume it when remembered. However, if the subsequent dose is imminent, bypass the forgotten one and proceed with the regular dosage schedule. Refrain from doubling up on doses. Seek advice from your physician for managing forgotten doses efficiently.